Pharmacological inhibition of PPARγ increases osteoblastogenesis and bone mass in male C57BL/6 mice.
about
Advances in the nutritional and pharmacological management of phenylketonuriaThe bone-fat interface: basic and clinical implications of marrow adiposityCircadian rhythms, Wnt/beta-catenin pathway and PPAR alpha/gamma profiles in diseases with primary or secondary cardiac dysfunction.FFA-ROS-P53-mediated mitochondrial apoptosis contributes to reduction of osteoblastogenesis and bone mass in type 2 diabetes mellitus.P-glycoprotein overexpression in bone marrow-derived multipotent stromal cells decreases the risk of steroid-induced osteonecrosis in the femoral head.Mechanisms of palmitate-induced cell death in human osteoblasts.Bone cell senescence: mechanisms and perspectives.Fat and bone interactions.Lentiviral delivery of PPARγ shRNA alters the balance of osteogenesis and adipogenesis, improving bone microarchitecture.Perspectives on osteoporosis therapies.Orexin Plays a Role in Growth Impediment Induced by Obstructive Sleep Breathing in Rats.Effect of zoledronic acid on vertebral marrow adiposity in postmenopausal osteoporosis assessed by MR spectroscopy.Palmitate attenuates osteoblast differentiation of fetal rat calvarial cells.Differential effects of bisphenol A diglicydyl ether on bone quality and marrow adiposity in ovary-intact and ovariectomized rats.MR spectroscopy for assessing the effects of oxytocin on marrow adipogenesis induced by glucocorticoid in rabbits.BADGE, a synthetic antagonist for PPARγ, prevents steroid-related osteonecrosis in a rabbit model.Curcumin Attenuates Pulmonary Inflammation in Lipopolysaccharide Induced Acute Lung Injury in Neonatal Rat Model by Activating Peroxisome Proliferator-Activated Receptor γ (PPARγ) Pathway.Marrow Adipose Tissue: Its Origin, Function, and Regulation in Bone Remodeling and Regeneration.The effect of vitamin D and zoledronic acid in bone marrow adiposity in kidney transplant patients: A post hoc analysis.
P2860
Q27006137-84FD2051-4F59-489D-8976-394BF494DA77Q27026998-D7251414-1A85-467C-86DF-ACA43273A526Q34452078-FC8AED87-8126-4CB2-9FCA-79370B7098BAQ35905850-C042CB47-457D-48D5-8D13-1D69F023BFA3Q37370772-CA3AFE88-2247-44EF-856F-E16C05422C44Q37392815-9205DA0A-32FD-420E-B7D9-70B6CB6A98F1Q38185298-5AFE6F92-2C0B-4946-A75F-E3080CEA7CC4Q38193721-02DE2302-99AA-4916-84A5-552197B05FC7Q38307418-10BDF36B-5409-4BBE-BEA7-881C271728E7Q38313739-F4921199-BA9E-4E09-8347-27801B259C88Q38998852-07361CC5-76CF-48BA-A52B-E159100859E5Q40780414-84AD1397-2E5B-4CF3-A27E-018075AFA18CQ41812310-2BD42A2C-DF73-4F3C-93A1-16D19ADD2969Q47976343-1BD74D3E-4BC3-408F-B233-D90F549761CBQ50993167-BECC60E1-16B5-4E06-B43A-47D8EE81C705Q55016052-B771628E-E334-4764-BD0F-A416B0B773A4Q55116610-4996EFB5-3876-4AC0-8D80-14ABE8B0C657Q55405123-96B703B7-8444-43CB-99C6-C008041E045FQ55435229-2ABBF331-AD41-4123-A943-1DBED23A912C
P2860
Pharmacological inhibition of PPARγ increases osteoblastogenesis and bone mass in male C57BL/6 mice.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Pharmacological inhibition of ...... one mass in male C57BL/6 mice.
@en
Pharmacological inhibition of ...... one mass in male C57BL/6 mice.
@nl
type
label
Pharmacological inhibition of ...... one mass in male C57BL/6 mice.
@en
Pharmacological inhibition of ...... one mass in male C57BL/6 mice.
@nl
prefLabel
Pharmacological inhibition of ...... one mass in male C57BL/6 mice.
@en
Pharmacological inhibition of ...... one mass in male C57BL/6 mice.
@nl
P2093
P2860
P356
P1476
Pharmacological inhibition of ...... one mass in male C57BL/6 mice.
@en
P2093
Christopher Vidal
Daniel Rivas
Janet Henderson
P2860
P304
P356
10.1002/JBMR.1782
P577
2013-03-01T00:00:00Z